视网膜母细胞瘤患者动脉内化疗术前的MRA检查
研究评估术前MRA识别眼动脉变异及脑膜中动脉至眼动脉/泪腺动脉吻合的能力,以辅助儿童视网膜母细胞瘤动脉内化疗的路径规划。13例患者共42次手术,MRA显示眼动脉起源12例(92%),吻合6例(46%)且均经DSA确认;无MRA吻合证据者DSA亦无吻合。总体手术成功率98%(41/42)。
要点
- 术前MRA可识别眼动脉起源变异及脑膜中动脉-眼动脉/泪腺动脉吻合,吻合均经DSA确认。
- MRA显示吻合的6例患者中,3例(50%)以脑膜中动脉-眼动脉吻合作为动脉内化疗的主要输送路径。
- MRA无吻合证据者DSA均未发现吻合;总体手术成功率98%(41/42)。
核心结论
- 术前MRA是识别眼动脉起源变异和脑膜中动脉-眼动脉吻合的准确工具,可能有助于优化儿童视网膜母细胞瘤的动脉内化疗输送并减少辐射。
研究设计与样本
- 回顾性研究,纳入2018年10月至2025年1月在一家三级儿童医院连续收治的接受动脉内化疗的视网膜母细胞瘤患者13例,共42次手术,中位年龄11个月(四分位距11-21个月);术前MRA评估眼动脉起源形态及脑膜中动脉-眼动脉吻合,以DSA确认。
诊断标准与关键数值
- MRA显示眼动脉起源12例(92%)。
- MRA显示脑膜中动脉-眼动脉/泪腺动脉吻合6例(46%),均经DSA确认。
- MRA无吻合证据的患者中,DSA均未发现吻合。
- 总体手术成功率98%(41/42)。
临床应用与阅片要点
- 术前MRA可用于识别眼动脉起源变异及脑膜中动脉-眼动脉/泪腺动脉吻合,可能辅助优化动脉内化疗输送路径并减少辐射。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Intra-arterial chemotherapy (IAC) is a potent treatment for patients with pediatric retinoblastoma (RB). Ophthalmic artery (OA) navigation via the ICA can be technically challenging; and in cases with robust anastomoses to the OA from the middle meningeal artery (MMA), the latter may serve as an alternative route. Our study evaluates the ability of preprocedural MRA to identify OA variants and the presence of MMA-to-OA/lacrimal artery (LA) anastomoses to enhance successful delivery of IAC in this population.
MATERIALS AND METHODS: Consecutive patients with RB admitted for IAC treatment at a tertiary pediatric hospital were identified from October 2018 to January 2025. The morphology of the OA origin and the presence of MMA-OA anastomoses were assessed on preprocedural MRA and confirmed on DSA.
RESULTS: A total of 13 patients who underwent 42 procedures were included, with a median age of 11 months (interquartile range, 11-21 months). The OA origin was visualized on MRA in 12 (92%) cases. MMA-OA/LA anastomoses were seen on MRA for 6 (46%) patients, all confirmed on DSA. Among patients with no MRA evidence of anastomoses, none were found to have anastomoses on DSA. MMA-OA anastomoses were used as the primary delivery route of IAC for 3 patients (50% of patients with a confirmed presence of MMA-OA anastomoses). Overall procedural success was 98% (41/42).
CONCLUSIONS: Preoperative MRA is an accurate tool for identifying OA origin variants and MMA-OA anastomoses, which may assist in optimizing IAC delivery for patients with pediatric RB, while minimizing radiation.
引用
- Colasurdo M, Pavlushkov E, Chen H, et al. Preoperative MRA for Patients with Retinoblastoma Undergoing Intra-Arterial Chemotherapy. AJNR Am J Neuroradiol. 2026. PMID: 41381354. doi:10.3174/ajnr.A8937
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。